Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 135

Sort by

Sort Order Select

Journal Articles

The Use of Post-Transplant Cyclophosphamide Leads to Increased Cardiac Complications without Affecting Survival in Haploidentical Stem Cell Transplantation

Tommy Alfaro, Nihar Desai, Maria Queralt Salas, Carol Chen, Armin Gerbitz, Dennis Dong Hwan Kim, Rajat Kumar, Wilson Lam, Arjun Law, Jeffrey H. Lipton, Fotios Michelis, Igor Novitzky-Basso, Jonas Mattsson, Auro Viswabandya

Blood (2024) 144 (Supplement 1): 7289.

https://doi.org/10.1182/blood-2024-205817

Published: 2024

Journal Articles

The Effect of Smoking and Pre-Transplant Pulmonary Comorbidity on the Incidence of Lung Graft Versus Host Disease and Post Transplant Outcomes

Mohammed Kawari, Mariana Pinto Pereira, Mats Remberger, Ambrose Lau, Arjun Law, Rajat Kumar, Igor Novitzky-Basso, Wilson Lam, Ivan Pasic, Armin Gerbitz, Auro Viswabandya, Dennis Dong Hwan Kim, Jonas Mattsson, Fotios Michelis

Blood (2024) 144 (Supplement 1): 2151.

https://doi.org/10.1182/blood-2024-204249

Published: 2024

Journal Articles

Superior Survival of Myeloablative over Reduced-Intensity Conditioning in MDS Patients below 65 Years Using a Combination of Antithymocyte Globulin and Post-Transplantation Cyclophosphamide As Gvhd Prophylaxis

Ahmed Alnughmush, Ruah Alyamany, Mats Remberger, Ivan Pasic, Igor Novitzky-Basso, Arjun Law, Wilson Lam, Dennis Dong Hwan Kim, Fotios Michelis, Armin Gerbitz, Rajat Kumar, Jonas Mattsson, Auro Viswabandya

Blood (2024) 144 (Supplement 1): 7285.

https://doi.org/10.1182/blood-2024-202708

Published: 2024

Journal Articles

Both Pre- and Post-Allogeneic Stem Cell Transplant Ferritin Are Associated with Relapse: A Large Single Centre Retrospective Study

Caden Chiarello, Mats Remberger, Carol Chen, Armin Gerbitz, Dennis Dong Hwan Kim, Rajat Kumar, Wilson Lam, Arjun Law, Jonas Mattsson, Fotios Michelis, Ivan Pasic, Auro Viswabandya, Igor Novitzky-Basso

Blood (2024) 144 (Supplement 1): 7384.

https://doi.org/10.1182/blood-2024-203265

Published: 2024

Journal Articles

Impact of Cyclosporine Exposure Levels on Outcomes in Allogeneic Hematopoietic Cell Transplantation: A Retrospective Analysis

Ahmed Alnughmush, Mats Remberger, Vathany Kulasingam, Ivan Pasic, Igor Novitzky-Basso, Arjun Law, Wilson Lam, Dennis Dong Hwan Kim, Armin Gerbitz, Auro Viswabandya, Rajat Kumar, Jonas Mattsson, Fotios Michelis

Blood (2024) 144 (Supplement 1): 7358.

https://doi.org/10.1182/blood-2024-202535

Published: 2024

Journal Articles

Survival and Engraftment Post Allogeneic Hematopoietic Stem Cell Transplantation: ABO Mismatch Matters in RIC

Nihar Desai, Tommy Alfaro Moya, Igor Novitzky-Basso, Ivan Pasic, Wilson Lam, Fotios Michelis, Armin Gerbitz, Dennis Dong Hwan Kim, Auro Viswabandya, Rajat Kumar, Jonas Mattsson, Arjun Law

Blood (2024) 144 (Supplement 1): 687.

https://doi.org/10.1182/blood-2024-194886

Published: 2024

Journal Articles

Expanding the Donor Pool, the Number of Antigen Mismatches Has No Impact in the Outcomes of Haploidentical Stem Cell Transplantation with Peripheral Blood Stem Cells and Dual T Cell Depletion

Tommy Alfaro, Nihar Desai, Carol Chen, Maria Queralt Salas, Igor Novitzky-Basso, Wilson Lam, Ivan Pasic, Arjun Datt Law, Fotios Michelis, Jeffrey H. Lipton, Armin Gerbitz, Rajat Kumar, Dennis Dong Hwan Kim, Jonas Mattsson, Auro Viswabandya

Blood (2024) 144 (Supplement 1): 2183.

https://doi.org/10.1182/blood-2024-199206

Published: 2024

Journal Articles

Improved Outcomes with Myeloablative Conditioning in AML Patients below 65 Years Using a Combination of Antithymocyte Globulin and Post-Transplantation Cyclophosphamide As Gvhd Prophylaxis

Blood (2024) 144 (Supplement 1): 7308.

https://doi.org/10.1182/blood-2024-202554

Published: 2024

Journal Articles

Real-World Efficacy of Belumosudil in Treating Fibrotic Symptom Burden in Chronic Gvhd: Modified Lee Symptom Score Assessment after Multiple Treatment Failures

Nihar Desai, Arjun Law, Christopher Lemieux, Keven Vachon, Kareem Jamani, Mohamed Elemary, Auro Viswabandya, Rajat Kumar, Jonas Mattsson, Dennis Dong Hwan Kim

Blood (2024) 144 (Supplement 1): 7353.

https://doi.org/10.1182/blood-2024-211615

Published: 2024

Journal Articles

Identification of High-Risk Patients and Establishment of a Clinical Prediction Model for Frontline Steroid Failure in Chronic Graft-Versus-Host-Disease

Arjun Pandey, Ivan Pasic, Igor Novitzky-Basso, Arjun Law, Wilson Lam, Fotios Michelis, Armin Gerbitz, Auro Viswabandya, Rajat Kumar, Jonas Mattsson, Dennis Dong Hwan Kim

Blood (2024) 144 (Supplement 1): 4899.

https://doi.org/10.1182/blood-2024-207936

Published: 2024

Journal Articles

Monocytes Matter: Impact of Monocyte Recovery on Allogeneic Hematopoietic Stem Cell Transplant Outcomes with Post-Transplantation Cyclophosphamide As Graft Versus Host Disease Prophylaxis

Nihar Desai, Tommy Alfaro Moya, Arjun Law, Wilson Lam, Igor Novitzky-Basso, Ivan Pasic, Fotios Michelis, Armin Gerbitz, Dennis Dong Hwan Kim, Rajat Kumar, Jonas Mattsson, Auro Viswabandya

Blood (2024) 144 (Supplement 1): 4896.

https://doi.org/10.1182/blood-2024-204123

Published: 2024

Journal Articles

Tolerability and Efficacy of Post-Transplant Cyclophosphamide in Older Adults Undergoing Matched Sibling Donor Allogeneic Transplantation: A Retrospective Analysis

Nihar Desai, Tommy Alfaro Moya, Igor Novitzky-Basso, Ivan Pasic, Wilson Lam, Fotios Michelis, Armin Gerbitz, Auro Viswabandya, Dennis Dong Hwan Kim, Rajat Kumar, Jonas Mattsson, Arjun Law

Blood (2024) 144 (Supplement 1): 4883.

https://doi.org/10.1182/blood-2024-204052

Published: 2024

Journal Articles

Haploidentical and Mismatched Unrelated Donor Allogeneic Hematopoietic Cell Transplantation in Patients with Myelofibrosis: A Retrospective Cohort Study

Nihar Desai, Arjun Law, Igor Novitzky-Basso, Ivan Pasic, Wilson Lam, Fotios Michelis, Armin Gerbitz, Dennis Dong Hwan Kim, Rajat Kumar, Jonas Mattsson, Auro Viswabandya

Blood (2024) 144 (Supplement 1): 4865.

https://doi.org/10.1182/blood-2024-204140

Published: 2024

Journal Articles

Strength to Endure: Superiority of MAC over RIC in Patients <65 Years Undergoing Stem Cell Transplantation Using ATG-Ptcy-CSA for Gvhd Prophylaxis

Ruah Alyamany, Ahmed Alnughmush, Mats Remberger, Fotios Michelis, Arjun D. Law, Wilson Lam, Dennis Dong Hwan Kim, Ivan Pasic, Igor Novitzky-Basso, Armin Gerbitz, Rajat Kumar, Jonas Mattsson, Auro Viswabandya

Blood (2024) 144 (Supplement 1): 4863.

https://doi.org/10.1182/blood-2024-202536

Published: 2024

Journal Articles

Outcomes of Patients with Accelerated/Blast-Phase MPNs That Received Allogeneic Stem-Cell Transplant in the Current Era of Myeloid Therapies

Blood (2023) 142 (Supplement 1): 3192.

https://doi.org/10.1182/blood-2023-174790

Published: 2023

Journal Articles

Clinical Factors but Not Somatic Mutations Predict for Survival in Patients with Myelofibrosis Undergoing Allogeneic Hematopoietic Cell Transplant: Analysis of the North American Myelofibrosis Transplant Outcome (NAMTO) Study

Blood (2023) 142 (Supplement 1): 3181.

https://doi.org/10.1182/blood-2023-173441

Published: 2023

Journal Articles

Use of Pre-Transplant Minicog Cognitive Impairment Screening and Validation of Frailty and Functionality Assessment Prior to Allogeneic Hematopoietic Stem Cell Transplantation

Tommy Alfaro, Maria Queralt Salas, Eshetu Atenafu, Ora Bascom, Leeann Wilson, Carol Chen, Arjun D. Law, Armin Gerbitz, Auro Viswabandya, Fotios Michelis, Jeffrey H. Lipton, Wilson Lam, Igor Novitzky-Basso, Dennis (Dong Hwan) Dong Hwan Kim, Jonas Mattsson, Ivan Pasic, Rajat Kumar

Blood (2023) 142 (Supplement 1): 5094.

https://doi.org/10.1182/blood-2023-191009

Published: 2023

Journal Articles

Outcomes of Allogeneic HSCT in Elderly Patients (70 years old and above) -a Canadian Experience

Yomna Eissa, Eshrak Al-Shaibani, Carol Chen, Shiyi Chen, Igor Novitzky-Basso, Arjun D. Law, Wilson Lam, Fotios Michelis, Auro Viswabandya, Armin Gerbitz, Ivan Pasic, Dennis D. H. Kim, Jeffrey H. Lipton, Jonas Mattsson, Rajat Kumar

Blood (2023) 142 (Supplement 1): 3733.

https://doi.org/10.1182/blood-2023-181118

Published: 2023

Journal Articles

Clinical, Cytogenetic and Immunophenotypic Spectra of Post-Transplant Relapse Following Allogeneic Hematopoietic Stem Cell Transplantation for Myelodysplastic Syndrome

Elizabeth Kathryn Herrity, Tommy Alfaro, Mariana Pinto Pereira, Igor Novitzky-Basso, Wilson Lam, Ivan Pasic, Fotios Michelis, Arjun D. Law, Auro Viswabandya, Adam Smith, Anne Maria Tierens, Armin Gerbitz, Rajat Kumar, Jonas Mattsson, Dennis D. H. Kim

Blood (2023) 142 (Supplement 1): 2206.

https://doi.org/10.1182/blood-2023-187145

Published: 2023

Journal Articles

Real World Experience of FLT3-Inhibitor Post-Transplant Maintenance with Sorafenib Demonstrating Superior Overall- and Relapse Free Survival Following Allogeneic Hematopoietic Stem Cell Transplantation in FLT3-ITD Mutated Acute Myeloid Leukemia

Yomna Eissa, Eshrak Al-Shaibani, Igor Novitzky-Basso, Ivan Pasic, Wilson Lam, Jose-Mario Capo-chichi, Arjun D. Law, Fotios Michelis, Auro Viswabandya, Armin Gerbitz, Rajat Kumar, Jonas Mattsson, Dennis D. H. Kim

Blood (2023) 142 (Supplement 1): 3589.

https://doi.org/10.1182/blood-2023-185951

Published: 2023

NARROW

The Use of Post-Transplant Cyclophosphamide Leads to Increased Cardiac Complications without Affecting Survival in Haploidentical Stem Cell Transplantation

The Effect of Smoking and Pre-Transplant Pulmonary Comorbidity on the Incidence of Lung Graft Versus Host Disease and Post Transplant Outcomes

Superior Survival of Myeloablative over Reduced-Intensity Conditioning in MDS Patients below 65 Years Using a Combination of Antithymocyte Globulin and Post-Transplantation Cyclophosphamide As Gvhd Prophylaxis

Both Pre- and Post-Allogeneic Stem Cell Transplant Ferritin Are Associated with Relapse: A Large Single Centre Retrospective Study

Impact of Cyclosporine Exposure Levels on Outcomes in Allogeneic Hematopoietic Cell Transplantation: A Retrospective Analysis

Survival and Engraftment Post Allogeneic Hematopoietic Stem Cell Transplantation: ABO Mismatch Matters in RIC

Expanding the Donor Pool, the Number of Antigen Mismatches Has No Impact in the Outcomes of Haploidentical Stem Cell Transplantation with Peripheral Blood Stem Cells and Dual T Cell Depletion

Improved Outcomes with Myeloablative Conditioning in AML Patients below 65 Years Using a Combination of Antithymocyte Globulin and Post-Transplantation Cyclophosphamide As Gvhd Prophylaxis

Real-World Efficacy of Belumosudil in Treating Fibrotic Symptom Burden in Chronic Gvhd: Modified Lee Symptom Score Assessment after Multiple Treatment Failures

Identification of High-Risk Patients and Establishment of a Clinical Prediction Model for Frontline Steroid Failure in Chronic Graft-Versus-Host-Disease

Monocytes Matter: Impact of Monocyte Recovery on Allogeneic Hematopoietic Stem Cell Transplant Outcomes with Post-Transplantation Cyclophosphamide As Graft Versus Host Disease Prophylaxis

Tolerability and Efficacy of Post-Transplant Cyclophosphamide in Older Adults Undergoing Matched Sibling Donor Allogeneic Transplantation: A Retrospective Analysis

Haploidentical and Mismatched Unrelated Donor Allogeneic Hematopoietic Cell Transplantation in Patients with Myelofibrosis: A Retrospective Cohort Study

Strength to Endure: Superiority of MAC over RIC in Patients <65 Years Undergoing Stem Cell Transplantation Using ATG-Ptcy-CSA for Gvhd Prophylaxis

Outcomes of Patients with Accelerated/Blast-Phase MPNs That Received Allogeneic Stem-Cell Transplant in the Current Era of Myeloid Therapies

Clinical Factors but Not Somatic Mutations Predict for Survival in Patients with Myelofibrosis Undergoing Allogeneic Hematopoietic Cell Transplant: Analysis of the North American Myelofibrosis Transplant Outcome (NAMTO) Study

Use of Pre-Transplant Minicog Cognitive Impairment Screening and Validation of Frailty and Functionality Assessment Prior to Allogeneic Hematopoietic Stem Cell Transplantation

Outcomes of Allogeneic HSCT in Elderly Patients (70 years old and above) -a Canadian Experience

Clinical, Cytogenetic and Immunophenotypic Spectra of Post-Transplant Relapse Following Allogeneic Hematopoietic Stem Cell Transplantation for Myelodysplastic Syndrome

Real World Experience of FLT3-Inhibitor Post-Transplant Maintenance with Sorafenib Demonstrating Superior Overall- and Relapse Free Survival Following Allogeneic Hematopoietic Stem Cell Transplantation in FLT3-ITD Mutated Acute Myeloid Leukemia

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only